Detailed Information

Cited 11 time in webofscience Cited 11 time in scopus
Metadata Downloads

Methylphenidate Extended Release (OROS MPH) for the Treatment of Antidepressant-Related Sexual Dysfunction in Patients With Treatment-Resistant Depression: Results From a 4-Week, Double-Blind, Placebo-Controlled Trial

Authors
Pae, Chi-UnMarks, David A.Masand, Prakash S.Peindl, KathleenHooper-Wood, ChristaHan, ChangsuMannelli, PaoloCiccone, PatrickPatkar, Ashwin A.
Issue Date
Mar-2009
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
methylphenidate; sexual dysfunction; treatment-resistant depression; augmentation
Citation
CLINICAL NEUROPHARMACOLOGY, v.32, no.2, pp.85 - 88
Indexed
SCIE
SCOPUS
Journal Title
CLINICAL NEUROPHARMACOLOGY
Volume
32
Number
2
Start Page
85
End Page
88
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/16211
DOI
10.1097/WNF.0b013e31817e559b
ISSN
0362-5664
Abstract
There are limited data to indicate effective treatment strategies for antidepressant-related sexual dysfunction, in particular for patients with treatment-resistant major depression. We subanalyzed our published data whether augmentation with methylphenidate extended release (OROS MPH) improved Sexual dysfunction associated with antidepressants in patients with treatment-resistant major depression. The primary efficacy measure was the change in Arizona Sexual Experiences Survey (ASEX) from baseline to end of treatment in an intent-to-treat analysis with last observation carried forward approach. There were no significant differences between the 2 groups in terms of changes in ASEX scores over time (F-1,F-35 (=) 1.14; P = 0.32), although the numerical decrease in ASEX score was greater in OROS MPH (mean change, -4.5; 20.1% decrease) than in the placebo group (mean change, -0.6; 2.6% decrease). Augmentation with OROS MPH showed no statistically significant benefit in antidepressant-related sexual dysfunction, although addition of OROS MPH to antidepressants did not worsen preexisting sexual dysfunction. Adequately powered controlled trials are needed to fully evaluate the efficacy of OROS MPH in this area.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Psychiatry > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Han, Changsu photo

Han, Changsu
구로병원 (Department of Psychiatry, Ansan Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE